Biotech/Pharma Stocks To Watch In The First Days Of February
The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine.
February Investments
8 Biotech Stocks Facing FDA Decisions In February
As January comes to a close, which biotech stocks await FDA decisions in February that could serve as catalysts?